verified SJR 0,779 · Q2 • database Scopus / SJR & Web of Science indexed

United Kingdom · SAGE Publications Ltd

workspace_premium Q2 — Rheumatology lock_open Open Access Unclaimed

Lupus

Lupus is a journal indexed in SJR in Rheumatology with an H index of 122. It has an SJR impact factor of 0,779 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,779.

Lupus focuses its scope in these topics and keywords: lupus, systemic, erythematosus, presenting, syndrome, response, review, antiphospholipid, cyclophosphamide, erythematosusthe, ...

ISSN: 0961-2033

Editorial: SAGE Publications Ltd

Category: Rheumatology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,779 Q2

H-index 122

Tasa de Aceptación pie_chart

24% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Open Access

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,779

H-index

122

Docs (year)

185

Docs 3y

686

Total refs

5750

Cites 3y

1514

Citable 3y

638

Cites/Doc 2y

1.96

Ref/Doc

31.08

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cardiac Tamponade in SLE

Visual disturbance by lymphocytic hypophysitis in a non-pregnant woman with systemic lupus erythematosus

Decreased expression of the p21ras stimulatory factor hSOS in PBMC from inactive SLE patients

Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta

Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases

CNS Lupus - Where Do We Go From Here?

Clinical evaluation and monitoring of lupus kidney disease

Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus

Chilblain lupus erythematosus is associated with antibodies to SSA/Ro

Cerebral vasculitis in a patient with hereditary complete C4 deficiency and systemic lupus erythematosus

Central nervous system lupus: a clinical approach to therapy

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations

SHOW MORE ARTICLES

Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations

1H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus

C1q inhibits autoantibody binding to calreticulin

Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study

Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype

Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis

Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE

Anti-beta2-glycoprotein I Antibody: Specificity and Clinical Significance

An outsider's view on SLE research

A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus

A Phospholipid-beta2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection

A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.